Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nojirimycine tetrazole is a synthetic small molecule belonging to the class of organic compounds known as tetrazoles. It is structurally related to nojirimycin and features a fused tetrazole ring. The compound acts as an inhibitor of glycogen phosphorylase (muscle form), an enzyme involved in glycogen breakdown. Nojirimycine tetrazole has been studied primarily as a research tool and experimental agent; it is not approved for clinical use in any country. Its main mechanism involves inhibition of muscle glycogen phosphorylase activity[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nojirimycine tetrazole.